Bellerophon Therapeutics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Bellerophon Therapeutics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Bellerophon Therapeutics (NASDAQ:BLPH) Will Have To Spend Its Cash Wisely
Jan 06
Bellerophon stock gains ~24% after getting FDA nod to reduce phase 3 study size
Sep 27Bellerophon Therapeutics GAAP EPS of -$0.43 beats by $0.17
Aug 15Is Bellerophon Therapeutics (NASDAQ:BLPH) In A Good Position To Invest In Growth?
Jan 18Bellerophon Therapeutics EPS misses by $0.01
Nov 05In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bellerophon Therapeutics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2023 | 6 | -9 | -12 | -12 | N/A |
| 6/30/2023 | 6 | -12 | -11 | -11 | N/A |
| 3/31/2023 | 6 | -11 | -10 | -10 | N/A |
| 12/31/2022 | N/A | -20 | -18 | -18 | N/A |
| 9/30/2022 | N/A | -19 | -17 | -17 | N/A |
| 6/30/2022 | N/A | -19 | -18 | -18 | N/A |
| 3/31/2022 | N/A | -18 | -20 | -20 | N/A |
| 12/31/2021 | N/A | -18 | -23 | -23 | N/A |
| 9/30/2021 | N/A | -21 | -25 | -25 | N/A |
| 6/30/2021 | N/A | -25 | -25 | -25 | N/A |
| 3/31/2021 | N/A | -25 | -23 | -23 | N/A |
| 12/31/2020 | N/A | -25 | -20 | -20 | N/A |
| 9/30/2020 | N/A | -21 | -16 | -16 | N/A |
| 6/30/2020 | N/A | -17 | -15 | -15 | N/A |
| 3/31/2020 | N/A | -17 | -15 | -15 | N/A |
| 12/31/2019 | N/A | -13 | -13 | -13 | N/A |
| 9/30/2019 | N/A | -10 | -14 | -14 | N/A |
| 6/30/2019 | N/A | 5 | -16 | -16 | N/A |
| 3/31/2019 | N/A | -2 | -17 | -17 | N/A |
| 12/31/2018 | N/A | 3 | -15 | -15 | N/A |
| 9/30/2018 | N/A | -20 | -16 | -16 | N/A |
| 6/30/2018 | N/A | -39 | -14 | -14 | N/A |
| 3/31/2018 | N/A | -32 | -13 | -13 | N/A |
| 12/31/2017 | N/A | -55 | -16 | -16 | N/A |
| 9/30/2017 | N/A | -38 | -14 | -14 | N/A |
| 6/30/2017 | N/A | -35 | N/A | -14 | N/A |
| 3/31/2017 | N/A | -36 | N/A | -14 | N/A |
| 12/31/2016 | N/A | -24 | N/A | -17 | N/A |
| 9/30/2016 | N/A | -27 | N/A | -32 | N/A |
| 6/30/2016 | N/A | -34 | N/A | -40 | N/A |
| 3/31/2016 | N/A | -41 | N/A | -44 | N/A |
| 12/31/2015 | N/A | -46 | N/A | -46 | N/A |
| 9/30/2015 | N/A | -48 | N/A | -41 | N/A |
| 6/30/2015 | N/A | -53 | N/A | -45 | N/A |
| 3/31/2015 | N/A | -58 | N/A | -49 | N/A |
| 12/31/2014 | N/A | -60 | N/A | -71 | N/A |
| 9/30/2014 | N/A | -64 | N/A | -71 | N/A |
| 3/31/2014 | N/A | -62 | N/A | -72 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BLPH's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if BLPH's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if BLPH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BLPH's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if BLPH's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BLPH's Return on Equity is forecast to be high in 3 years time